STEDNAC

This brand name is authorized in Nigeria

Active ingredients

The drug STEDNAC contains a combination of these active pharmaceutical ingredients (APIs):

1 Aceclofenac
UNII RPK779R03H - ACECLOFENAC

Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins.

Read about Aceclofenac
2 Linseed oil
UNII 84XB4DV00W - LINSEED OIL
3 Methyl salicylate
UNII LAV5U5022Y - METHYL SALICYLATE

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.

Read about Methyl salicylate
4 Menthol
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
Read about Menthol
5 Benzyl alcohol
UNII LKG8494WBH - BENZYL ALCOHOL

Benzyl alcohol inhibits lice from closing their respiratory spiracles, allowing the vehicle to obstruct the spiracles and causing the lice to asphyxiate.

Read about Benzyl alcohol

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: NG Registered Drug Product Database Identifier(s): A4-100649

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.